Kim, C., Yoon, H., Park, M., Yoo, K., Jung, K., Park, J., . . . Yoo, C. (2017). Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: Results from the randomized INFINITY study. Int J Chron Obstruct Pulmon Dis.
Citación estilo ChicagoKim, Cheong-Ju, et al. "Inhaled Indacaterol for the Treatment of COPD Patients With Destroyed Lung By Tuberculosis and Moderate-to-severe Airflow Limitation: Results From the Randomized INFINITY Study." Int J Chron Obstruct Pulmon Dis 2017.
Cita MLAKim, Cheong-Ju, et al. "Inhaled Indacaterol for the Treatment of COPD Patients With Destroyed Lung By Tuberculosis and Moderate-to-severe Airflow Limitation: Results From the Randomized INFINITY Study." Int J Chron Obstruct Pulmon Dis 2017.